Sai Life Sciences
SAILIFE · Pharma > Pharmaceuticals & Drugs Listing date: Dec. 18, 2024

Stock Price vs Company Growth
1d
2.6%
1w
4.4%
1m
14.8%
3m
31.6%
6m
27.7%
1y
58.3%
all
31.4%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 1,117 2.6%
857
1,124
Company Overview

Sales
2,170 Cr
Growth: 29.1%
Profit after Tax
333 Cr
Growth: 16.2%
Mid Cap
23,683 Cr
P/E: 71.4x
Industry P/E: 30.4x
Fundamentals

Sales (Cr) ₹ 2,170
Growth 29.1%
EBITDA 28.2%
P/S 10.9x
Dividend 0.0%
P/E 71.4x
Book Value ₹ 112
PEG Ratio 2.4x
ROE 14.9%
P/B 9.9x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

The company is a pure play fully-integrated, innovator-focused, contract research, development and manufacturing organization. It provides end-to-end services across the drug discovery, development and manufacturing value chain for small molecule new chemical entities to global pharmaceutical innovators companies and biotechnology firms.
Followers (1)